The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors. A review of the current literature.

M. Giuffré, M. Campigotto, A. Colombo, A. Visintin, M. Budel, A. Aversano, L. Navarria, A. Piccin, C. Cavalli, R. Sigon, Fabio Tiné, C. Abazia, F. Masutti, L. Crocè
{"title":"The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors. A review of the current literature.","authors":"M. Giuffré, M. Campigotto, A. Colombo, A. Visintin, M. Budel, A. Aversano, L. Navarria, A. Piccin, C. Cavalli, R. Sigon, Fabio Tiné, C. Abazia, F. Masutti, L. Crocè","doi":"10.23736/S1121-421X.20.02777-4","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nAlcohol-related liver disease (ALD) was estimated to have a prevalence of 2% among the United States population. Since severe fibrosis in compensated patients is the main predictor of long-term survival, it is of utmost importance to early detect patients with severe fibrosis before decompensation occurs. Liver elastography has been used to stage liver fibrosis. However, there is a widespread lack in guidelines for the correct use of liver stiffness (LS) in ALD.\n\n\nEVIDENCE ACQUISITION\nA structured search was carried out on MEDLINE/PubMed database. From the original 225 research articles identified, only 12 studies met the inclusion criteria, with 10 studies being eventually included.\n\n\nEVIDENCE SYNTHESIS\nAccording to reported data, patients with aspartate aminotransferase (AST) > 100 IU/L and 50 IU/L showed significantly higher values of LS if compared to patients with the same fibrosis stage. Also, excessive alcohol consumption greatly influences elastography, leading to false fibrosis staging. When LS values > 5-6 kPa are detected, several aspects should be taken into account. First of all, the patient should be asked about the current alcohol consumption (i.e., active vs. abstinence, determination of abstinence period, and quantification of alcohol intake), and if the patient is an active drinker, liver elastography can be repeated after a complete abstinence period of at least two weeks. and if the patient is an active drinker, liver elastography can be repeated after a complete abstinence period of at least two weeks. Secondly, clinicians should check liver transaminases level, and if AST are above 100 IU/L, they should be aware of a possible overestimation of fibrosis. However, whether transaminases-adapted cut-off values should be used for ad hoc decisions in patients with no time or option to withdraw from alcohol consumption is still a matter of debate.\n\n\nCONCLUSIONS\nWe hope that our review article may serve as a reference point in the prospect of futures guidelines.","PeriodicalId":74201,"journal":{"name":"Minerva gastroenterologica e dietologica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva gastroenterologica e dietologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S1121-421X.20.02777-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION Alcohol-related liver disease (ALD) was estimated to have a prevalence of 2% among the United States population. Since severe fibrosis in compensated patients is the main predictor of long-term survival, it is of utmost importance to early detect patients with severe fibrosis before decompensation occurs. Liver elastography has been used to stage liver fibrosis. However, there is a widespread lack in guidelines for the correct use of liver stiffness (LS) in ALD. EVIDENCE ACQUISITION A structured search was carried out on MEDLINE/PubMed database. From the original 225 research articles identified, only 12 studies met the inclusion criteria, with 10 studies being eventually included. EVIDENCE SYNTHESIS According to reported data, patients with aspartate aminotransferase (AST) > 100 IU/L and 50 IU/L showed significantly higher values of LS if compared to patients with the same fibrosis stage. Also, excessive alcohol consumption greatly influences elastography, leading to false fibrosis staging. When LS values > 5-6 kPa are detected, several aspects should be taken into account. First of all, the patient should be asked about the current alcohol consumption (i.e., active vs. abstinence, determination of abstinence period, and quantification of alcohol intake), and if the patient is an active drinker, liver elastography can be repeated after a complete abstinence period of at least two weeks. and if the patient is an active drinker, liver elastography can be repeated after a complete abstinence period of at least two weeks. Secondly, clinicians should check liver transaminases level, and if AST are above 100 IU/L, they should be aware of a possible overestimation of fibrosis. However, whether transaminases-adapted cut-off values should be used for ad hoc decisions in patients with no time or option to withdraw from alcohol consumption is still a matter of debate. CONCLUSIONS We hope that our review article may serve as a reference point in the prospect of futures guidelines.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
弹性成像在酒精性肝病中的作用:纤维化分期和混杂因素。当前文献综述。
酒精相关性肝病(ALD)在美国人群中的患病率估计为2%。由于代偿患者的严重纤维化是长期生存的主要预测因素,因此在代偿失代偿发生前早期发现严重纤维化患者至关重要。肝弹性成像已被用于肝纤维化分期。然而,普遍缺乏在ALD中正确使用肝硬度(LS)的指南。证据获取在MEDLINE/PubMed数据库中进行结构化检索。在最初确定的225篇研究文章中,只有12篇研究符合纳入标准,最终纳入了10篇研究。据报道,与相同纤维化分期的患者相比,天冬氨酸转氨酶(AST) > 100 IU/L和50 IU/L的患者LS值显著升高。此外,过量饮酒极大地影响弹性成像,导致假纤维化分期。当检测到LS值> 5-6 kPa时,需要考虑以下几个方面:首先,应询问患者目前的饮酒情况(即主动与戒酒,确定戒酒期,量化酒精摄入量),如果患者是主动饮酒者,可在至少两周的完全戒酒期后重复肝脏弹性成像。如果患者是一个活跃的饮酒者,肝脏弹性成像可以在至少两周的完全戒断期后重复进行。其次,临床医生应检查肝脏转氨酶水平,如果AST高于100 IU/L,应注意可能高估纤维化。然而,在没有时间或选择戒酒的患者中,转氨酶适应临界值是否应该用于临时决定仍然是一个有争议的问题。结论我们的综述文章可以为未来指南的制定提供参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations. Liver and spleen elastography as predictor of portal hypertension and esophageal varices. Bleeding peptic ulcer disease: over or through the scope clipping? Liver fibrosis in NAFLD patients: examining the opportunity to find a non-invasive, accurate and low-cost tool. What does liver elastography measure? Technical aspects and methodology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1